1078 related articles for article (PubMed ID: 27823684)
41. Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.
Levy ME; Greenberg AE; Magnus M; Younes N; Castel A
AIDS Patient Care STDS; 2018 Feb; 32(2):58-69. PubMed ID: 29561173
[TBL] [Abstract][Full Text] [Related]
42. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
[TBL] [Abstract][Full Text] [Related]
43. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
[TBL] [Abstract][Full Text] [Related]
44. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
McBride CL; Akeroyd JM; Ramsey DJ; Nambi V; Nasir K; Michos ED; Bush RL; Jneid H; Morris PB; Bittner VA; Ballantyne CM; Petersen LA; Virani SS
Vasc Med; 2018 Jun; 23(3):232-240. PubMed ID: 29600737
[TBL] [Abstract][Full Text] [Related]
45. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Verma AA; Jimenez MP; Subramanian SV; Sniderman AD; Razak F
Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28912201
[TBL] [Abstract][Full Text] [Related]
46. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
47. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
Schwartz GG; Bessac L; Berdan LG; Bhatt DL; Bittner V; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Mahaffey KW; Moryusef A; Pordy R; Roe MT; Rorick T; Sasiela WJ; Shirodaria C; Szarek M; Tamby JF; Tricoci P; White H; Zeiher A; Steg PG
Am Heart J; 2014 Nov; 168(5):682-9. PubMed ID: 25440796
[TBL] [Abstract][Full Text] [Related]
48. Temporal trends in the use of high-dose potent statins following acute coronary syndrome in Israel.
Elis A; Pereg D; Dicker D; Gevrielov-Yusim N; Goldenberg I; Matetzky S; Kopel E; Klempfner R
Cardiology; 2014; 128(3):266-72. PubMed ID: 24863615
[TBL] [Abstract][Full Text] [Related]
49. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
[TBL] [Abstract][Full Text] [Related]
50. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome.
Wongsalap Y; Jedsadayanmata A
J Cardiol; 2020 Mar; 75(3):275-281. PubMed ID: 31519405
[TBL] [Abstract][Full Text] [Related]
51. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
Bin Abdulhak AA; Vaughan-Sarrzin M; Kaboli P; Horwitz PA; Mosher H; Sigurdsson G; Walker NE; Wallace R; Robinson JG
J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29503265
[TBL] [Abstract][Full Text] [Related]
52. Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.
Phan BAP; Weigel B; Ma Y; Scherzer R; Li D; Hur S; Kalapus SC; Deeks S; Hsue P
Circ Cardiovasc Imaging; 2017 Jul; 10(7):e005995. PubMed ID: 28674084
[TBL] [Abstract][Full Text] [Related]
53. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
[TBL] [Abstract][Full Text] [Related]
54. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
55. In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a U.S. cohort.
Wadia SK; Belkin M; Chow KS; Nattiv J; Appis A; Feinstein SB; Williams KA
Hosp Pract (1995); 2017 Feb; 45(1):16-20. PubMed ID: 28092990
[TBL] [Abstract][Full Text] [Related]
56. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
57. Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project.
Miedema MD; Sidebottom AC; Sillah A; Benson G; Knickelbine T; VanWormer JJ
J Clin Lipidol; 2017; 11(1):94-101. PubMed ID: 28391916
[TBL] [Abstract][Full Text] [Related]
58. Assessment of compliance with lipid guidelines in an academic medical center.
Schwiesow SJ; Nappi JM; Ragucci KR
Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
[TBL] [Abstract][Full Text] [Related]
59. Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Konstantara F; Savopoulos C; Hatzitolios AI
Atherosclerosis; 2015 Nov; 243(1):65-70. PubMed ID: 26355807
[TBL] [Abstract][Full Text] [Related]
60. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
Heller DJ; Coxson PG; Penko J; Pletcher MJ; Goldman L; Odden MC; Kazi DS; Bibbins-Domingo K
Circulation; 2017 Sep; 136(12):1087-1098. PubMed ID: 28687710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
